Copyright
©The Author(s) 2016.
World J Gastroenterol. Oct 21, 2016; 22(39): 8770-8778
Published online Oct 21, 2016. doi: 10.3748/wjg.v22.i39.8770
Published online Oct 21, 2016. doi: 10.3748/wjg.v22.i39.8770
Figure 1 Curves for predicting esophageal lesions based on positive expression of the three biomarkers.
These ROC curves are for ESCC (A), HGD (B), LGD (C), and BCH (D), respectively. Note: If the expression of any one of the three biomarkers was positive, the combined expression was counted as positive; if there was an overlap in expression, the score of the strongest expression was taken as the score of the combination. ESCC: Esophageal squamous cell cancer; HGD: High-grade dysplasia; LGD: Low-grade dysplasia; BCH: Basal cell hyperplasia; ROC: Receiver operating characteristic curve.
- Citation: Zhang H, Li H, Ma Q, Yang FY, Diao TY. Predicting malignant transformation of esophageal squamous cell lesions by combined biomarkers in an endoscopic screening program. World J Gastroenterol 2016; 22(39): 8770-8778
- URL: https://www.wjgnet.com/1007-9327/full/v22/i39/8770.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i39.8770